Anondita Medicare Fair Value
ANONDITA · Consumer Goods · Current price ₹1,040.7
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹223 | 40% ROE fading to 13% over ~10 yrs, on ₹72 book |
| Relative P/E | ₹576 | EPS × 31.1 peer-median P/E |
| Graham floor | ₹172 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is Anondita Medicare undervalued?
DocStoX estimates the fair value of Anondita Medicare at ₹314 per share, versus the current market price of ₹1,041. That puts the stock about -69.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹223), Relative P/E (₹576), Graham floor (₹172). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹172 (bear) to ₹314 (base) to ₹576 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Anondita Medicare
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.